This inventor holds 9 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Csl Limited, Csl Behring Gmbh. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Muri, CH (2016 - 2021)
- Guemligen, CH (2022)
Company Filing History:
Years Active: 2016-2022
Title: **The Innovative Contributions of Sabine Zollner**
Introduction
Sabine Zollner, an accomplished inventor based in Muri, Switzerland, has made significant advancements in the field of biotechnology. With a total of nine patents to her name, her work focuses primarily on improving the stability and bioavailability of therapeutic proteins, particularly Factor VIII, which is crucial for treating hemophilia.
Latest Patents
Among her most notable contributions are her recent patents related to the "Method for improving the stability of purified Factor VIII after reconstitution." This innovation outlines a method aimed at enhancing the stability of the Factor VIII molecule post-purification, lyophilization, and reconstitution. The process involves preventing proteolytic cleavage of the Factor VIII molecule into fragments that include essential domains, thereby maintaining its integrity throughout manufacturing. Additionally, her disclosures emphasize methods to improve the bioavailability of Factor VIII following both intravenous and non-intravenous injections, highlighting her commitment to advancing treatment efficacy for patients.
Career Highlights
Sabine Zollner has built her career by working with leading companies in the biotechnology industry, such as CSL Limited and CSL Behring GmbH. Her role in these organizations has enabled her to apply her innovative ideas to real-world applications, making a substantial impact on healthcare and patient outcomes.
Collaborations
Throughout her career, Zollner has collaborated with talented professionals including Hubert Metzner and Stefan Schulte. These partnerships have fostered an environment of innovation and creativity, further enhancing her contributions to the field.
Conclusion
Sabine Zollner's work exemplifies the spirit of innovation in biotechnology. Her nine patents reflect her dedication to improving therapeutic methods, specifically for sensitive treatments such as Factor VIII. As she continues to push the boundaries of medical science, her contributions will undoubtedly remain influential in shaping the future of biotechnology and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile